A Pilot Trial of Rituxan in Refractory Myasthenia Gravis

Clinical trial NCT00619671 · COMPLETED

Trial details

NCT number: NCT00619671
Sponsor: University of Vermont
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Refractory Myasthenia Gravis

Start date: 2004-04-01
Primary completion: 2009-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.